New diabetes drug tested in kidney patients
NCT ID NCT06929156
First seen Feb 17, 2026 · Last updated May 25, 2026 · Updated 12 times
Summary
This study looked at how the body handles BGM0504, a potential treatment for type 2 diabetes and obesity, in people with different levels of kidney function. Researchers compared 34 participants with normal kidneys to those with mild or moderate kidney impairment. The goal was to understand how quickly the drug enters the blood and how long it stays in the body, which helps determine safe dosing for patients with kidney issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital, Shandong Province)
Jinan, Shandong, 650100, China
Conditions
Explore the condition pages connected to this study.